GENE ONLINE|News &
Opinion
Blog

Series A Funding
Protect Bio Completed Series A Fundraising, Establishing New Platform for Animal Therapy
2023-12-11Partner
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Flossy Raises 14.7M to Expand Oral Care Accessibility
2022-08-19
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Boston’s Kelonia Therapeutics Bags $50M to Accelerate Genetic Medicines
2022-04-29
Pheast Gets a $76 Million Series A to Feed Pipeline of Immune Checkpoint Inhibitors
2022-04-27
tRNA Startup Clinches $24 Million from ARCH, Takeda and 8VC to Fix Protein Mutations
2022-02-25
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
SK Biopharm Spinout Launches with $180 Million to Bring Neuroscience Drugs to China
2021-11-12
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Replicate Bioscience Secures $40 Million in Series A to Advance RNA Therapeutics
2021-09-10
GenScript’s Biotech Unit, ProBio Bags $150 Million in Series A from Hillhouse Capital
2021-08-20
1 2 3
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top